Goto M, Fujioka I, Ogawa Y, Koinuma S, Yamaguchi K: Limitations of FAERS-based analyses of paternal drug exposure: The critical need for maternal data integration. Andrology. 2025 Oct 3. doi: 10.1111/andr.70126. Online ahead of print.
Goto M, Kohno C, Takai C, Miyagawa E, Yanai R, Yajima N, Kaneko Y, Tanaka E, Kawahito Y, Harigai M, Kaneko K: Systematic review of the treatment of rheumatoid arthritis patients of reproductive age: Informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis – secondary publication. Mod Rheumatol. 2025 Oct 8: roaf 087. doi: 10.1093/mr/roaf087. Online ahead of print.
Matsuda S, Yakuwa N, Goto M, Akazawa M, Takahashi K, Anzai T, Koinuma S, Fujioka I, Miura Y, Ota M, Oka H, Nitani N, Tawaragi T, Murashima A: Evaluation of Data Quality and Utility of the Japan Drug Information Institute in Pregnancy (JDIIP) Consultation Case Database for Pregnancy Pharmacovigilance. Drug Saf. 2025 Sep;48(9):1035-1046
Koinuma S, Goto M, Saito J, Murashima A, Takeshita T: Transfer of amenamevir into breast milk in breastfeeding patients with recurrent herpes simplex: study protocol for a single-arm, open-label study. Front Pediatr. 2025; 13:1551335. doi: 10.3389/fped.2025.1551335. eCollection 2025.
Ohtsu H, Fujioka I*, Goto M, Takai C, Yonemoto N, Sase K, Murashima A: Five-Year Delivery Rate and Time to Delivery Among Women With and Without Rheumatoid Arthritis: A Real-World Analysis Using a Nationwide Claims Database in Japan. Int J Rheum Dis. 2025;28(6): e70296. *Corresponding author
Hirasawa Y, Tagashira H, Ueno A, Tasaka Y, Goto M*, Murashima A, Yamamoto H: Maternal Mosapride Citrate Hydrate Exposure During the First Trimester: Assessing Risks for Congenital Anomalies. Dig Dis Sci. 2025 Jul 9. doi: 10.1007/s10620-025-09197-3. Online ahead of print. *Corresponding author
Hongoh M, Fujioka I, Goto M, Yamane R, Tamaki H, Murashima A, Yano T: Evaluation of the Safety of Lansoprazole Exposure During Early Pregnancy: A Prospective Cohort Study Using Two-Center Counseling Data in Japan. Yakugaku Zasshi. 2025;145(12):967-973
Goto M, Saito S, Scheuerle A, Yasuda S, Houston N, Kumke T, Lauwerys B, Murashima A: Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol. Int J Rheum Dis. 2025 Jan;28(1):e70048.
Usuda M, Jwa SC, Goto M, Kobayashi M, Nagano H, Yakuwa N, Yamane R, Murashima A, Makabe H: Risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy. Congenit Anom (Kyoto). 2024;64(3):91-98
Miki Y, Koga Y, Taogoshi T, Itamura R, Yokooji T, Hishinuma K, Yakuwa N, Goto M, Murashima A, Matsuo H: Assessment of the Safety of Exposure to Cefcapene Pivoxil during the First Trimester of Pregnancy: A Prospective Cohort Study in Japan. Biol Pharm Bull. 2024;47(7):1301-1306
Goto M, Anzai T, Yamane R, Yakuwa N, Takahashi K, Murashima A: Pregnancy outcomes after first-trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions. Congenit Anom (Kyoto). 2024;64(5):199-206
Nishimura A, Furugen A, Kobayashi M, Takekuma Y, Yakuwa N, Goto M, Hayashi M, Murashima A, Sugawara M: Effects of famotidine use during pregnancy: an observational cohort study. J Pharm Health Care Sci. 2024;10(1):70
Koinuma S, Sasaki A, Murayama K, Sueoka K, Murashima A, Kasahara M: Successful pregnancy in a patient with OTCD using advanced technologies and liver transplant. Pediatr Int. 2025;67(1):e70006
Honma M, Suzuki N, Goto M, Obara T, Saito Y, Nakajima K, Yamane R, Takahashi K, Nakayama T, Hayashi M, Murashima A, Toyama A: A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan. Congenit Anom (Kyoto). 2025;65(1):e12588
Saito J, Yakuwa N, Hosokawa Y, Hamada H, Suzuki T, Sago H, Kaneko K, Yamatani A, Murashima A: Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi-institutional study. Br J Clin Pharmacol. 2024;90(1):146-157
Yakuwa N, Murashima A, Miyazaki S: Investigation on the accumulation of background and pregnancy outcome information on cases consulted by the Japan Drug Information Institute in Pregnancy. Congenit Anom (Kyoto). 2024;64(1):6-16
Saito J, Ishii M, Sandaiji N, Yamaguchi K, Suzuki T, Yakuwa N, Yamatani A, Tachibana Y, Sago H, Murashima A: Lemborexant levels in maternal serum, cord blood, and breast milk during pregnancy and lactation: A case report. PCN Rep. 2023;2(1):e62
Ishige T, Shimizu T, Watanabe K, Arai K, Kamei K, Kudo T, Kunisaki R, Tokuhara D, Naganuma M, Mizuochi T, Murashima A, Inoki Y, Iwata N, Iwama I, Koinuma S, Shimizu H, Jimbo K, Takaki Y, Takahashi S, Cho Y, Nambu R, Nishida D, Hagiwara SI, Hikita N, Fujikawa H, Hosoi K, Hosomi S, Mikami Y, Miyoshi J, Yagi R, Yokoyama Y, Hisamatsu T: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan. J Gastroenterol. 2023;58(2):135-157
拠点病院関係者ページ